Home LiteratureArticle Details
PMID: 7341283 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Differential induction of antipyrine metabolism by rifampicin.

European journal of clinical pharmacology ·Vol. 21 ·No. 2 ·1981-00-00 ·Pages 155-60

Toverud EL, Boobis AR, Brodie MJ, Murray S, Bennett PN, Whitmarsh V, Davies DS

Abstract

Antipyrine is oxidised to three main metabolites in man. There is evidence that the different metabolites are products of different forms of cytochrome P-450. The effect of rifampicin administration for two weeks on the rates of formation of these metabolites was investigated in healthy volunteers. Rifampicin increased antipyrine clearance and shortened its half-life. Two weeks after stopping rifampicin the induction had largely been reversed. Clearance to all three metabolites was increased by rifampicin. Clearance to 3-hydroxymethylantipyrine was increased from 7.8 +/- 0.9 ml/min to 13.3 +/- 1.3 ml/min, to norphenazone from 5.8 +/- 0.6 ml/min to 19.3 +/- 2.1 ml/min and to 4-hydroxyantipyrine from 14.3 +/- 2.2 ml/min to 21.9 +/- 3.9 ml/min. Thus clearance to norphenazone was increased to a much greater extent than to either of the other two metabolites. It is concluded that this provides evidence for the involvement of at least two different forms of cytochrome P-450 in antipyrine metabolism in man.

MeSH Terms
Adult Antipyrine/metabolism Cytochrome P-450 Enzyme System/biosynthesis Enzyme Induction Half-Life Humans Kinetics Male Metabolic Clearance Rate Rifampin/pharmacology
Chemicals
Cytochrome P-450 Enzyme System Antipyrine Rifampin
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Toverud E L
Boobis A R
Brodie M J
Murray S
Bennett P N
Whitmarsh V
Davies D S
References (26)
26 references, click to expand
  1. Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers.
    Br J Clin Pharmacol. 1979 Dec;8(6):529-37 PMID: 533575
  2. The antipyrine test in clinical pharmacology: conceptions and misconceptions.
    Clin Pharmacol Ther. 1979 Sep;26(3):275-86 PMID: 111889
  3. Induction of hepatic microsomal enzymes after brief administration of rifampicin in man.
    Gastroenterology. 1977 May;72(5 Pt 1):924-6 PMID: 849823
  4. Influence of inducers and inhibitors on the hydroxylation pattern of N-hexane in rat liver microsomes.
    FEBS Lett. 1974 Apr 15;41(1):14-6 PMID: 4852437
  5. Regioselective and stereoselective hydroxylation of R and S warfarin by different forms of purified cytochrome P-450 from rabbit liver.
    J Biol Chem. 1978 Nov 10;253(21):7813-20 PMID: 701290
  6. 4,4'-Dihydroxyphenazone as an urinary metabolite of phenazone in different species including man.
    Naunyn Schmiedebergs Arch Pharmacol. 1979 Nov;309(2):203-5 PMID: 522906
  7. Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration.
    Clin Pharmacol Ther. 1974 Dec;16(6):1059-65 PMID: 4611464
  8. Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in man.
    Pharmacology. 1979;18(4):210-23 PMID: 461498
  9. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.
    Xenobiotica. 1979 Nov;9(11):695-702 PMID: 119355
  10. The effect of spironolactone on antipyrine metabolism in man.
    Pharmacology. 1973;10(6):338-44 PMID: 4593769
  11. The role of cytochrome P-450 in N-hydroxylation of 2-acetylaminofluorene.
    Mol Pharmacol. 1973 May;9(3):398-404 PMID: 4122821
  12. Dose-dependent enzyme induction.
    Clin Pharmacol Ther. 1973 Jul-Aug;14(4):514-20 PMID: 4723259
  13. The stimulation of hydroxylation by carcinogenic and non-carcinogenic compounds.
    Biochem Pharmacol. 1966 Jan;15(1):7-18 PMID: 4161076
  14. Differences in P-450 cytochromes from livers of rats treated with phenobarbital and with 3-methylcholanthrene.
    J Biol Chem. 1973 Mar 25;248(6):2192-201 PMID: 4690601
  15. An improved combined gas chromatographic mass spectrometric assay for the estimation of norphenazone in urine.
    Biomed Mass Spectrom. 1980 Apr;7(4):179-82 PMID: 7448333
  16. Separation and purification of multiple forms of microsomal cytochrome P-450. Activities of different forms of cytochrome P-450 towards several compounds of environmental interest.
    J Biol Chem. 1977 Jun 10;252(11):3970-9 PMID: 405388
  17. Metabolism of drugs. LXX. Further study on antipyrine metabolism.
    Chem Pharm Bull (Tokyo). 1971 Jan;19(1):41-5 PMID: 5544367
  18. Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine.
    Clin Pharmacol Ther. 1977 Apr;21(4):470-81 PMID: 849678
  19. The fate of antipyrine in man.
    J Pharmacol Exp Ther. 1950 Jan;98(1):97-104 PMID: 15403625
  20. Antipyrine as an in vitro probe of mixed function oxidase activity [proceeding].
    Br J Clin Pharmacol. 1980 Mar;9(3):284P PMID: 7362740
  21. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase.
    J Biol Chem. 1976 Aug 25;251(16):4936-46 PMID: 956169
  22. Studies on the different metabolic pathways of antipyrine as a tool in the assessment of the activity of different drug metabolizing enzyme systems in man [proceedings].
    Br J Pharmacol. 1980 Jan;68(1):121P PMID: 7357141
  23. Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxy antipyrine in the urine of man.
    Biochem Pharmacol. 1974 Jan 15;23(2):197-201 PMID: 4813341
  24. Rapid gas-liquid chromatographic estimation of antipyrine in plasma.
    J Pharm Pharmacol. 1973 Mar;25(3):205-7 PMID: 4146319
  25. Rifampicin and vitamin D metabolism.
    Clin Pharmacol Ther. 1980 Jun;27(6):810-4 PMID: 7379450
  26. Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.
    Eur J Clin Pharmacol. 1979 Mar 26;15(2):139-45 PMID: 35353
Article Info
Journal
European journal of clinical pharmacology
Abbr.
Eur J Clin Pharmacol
ISSN
0031-6970
Published
1981-00-00
Pages
155-60
Language
English
Region
Germany
NLM ID
1256165
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]